Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ballow

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology|January 10, 2017
Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)Mark Ballow, Mark R Conaway, Panida Sriaroon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2026
Recommended Vaccines for Immunocompetent Older Adults: Work Group Report of the AAAAI Allergy and Asthma in Older Adults CommitteeJonathan Slimovitch, Richard F Lockey, Anna Chen Arroyo, et al.
Clinical Immunology (Orlando, Fla.)|July 12, 2017
Idiopathic T cell lymphopenia identified in New York State Newborn ScreeningStephanie Albin-Leeds, Juliana Ochoa, Harshna Mehta, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Clinical Immunology (Orlando, Fla.)|November 17, 2009
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and ImmunologyPierre L Yong, John Boyle, Mark Ballow, et al.
The Journal of Allergy and Clinical Immunology|February 17, 2022
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response CommitteesIris M Otani, Heather K Lehman, Artemio M Jongco, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2017
Update on the use of immunoglobulin in human disease: A review of evidenceElena E Perez, Jordan S Orange, Francisco Bonilla, et al.
Journal of Clinical Immunology|March 1, 2014
Newborn screening for SCID in New York State: experience from the first two yearsBeth H Vogel, Vincent Bonagura, Geoffrey A Weinberg, et al.
The Journal of Allergy and Clinical Immunology|April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJordan S Orange, Elham M Hossny, Catherine R Weiler, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & ImmunologyJordan S Orange, Mark Ballow, E Richard Stiehm, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|January 10, 2017
Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)Mark Ballow, Mark R Conaway, Panida Sriaroon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2026
Recommended Vaccines for Immunocompetent Older Adults: Work Group Report of the AAAAI Allergy and Asthma in Older Adults CommitteeJonathan Slimovitch, Richard F Lockey, Anna Chen Arroyo, et al.
Clinical Immunology (Orlando, Fla.)|July 12, 2017
Idiopathic T cell lymphopenia identified in New York State Newborn ScreeningStephanie Albin-Leeds, Juliana Ochoa, Harshna Mehta, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Clinical Immunology (Orlando, Fla.)|November 17, 2009
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and ImmunologyPierre L Yong, John Boyle, Mark Ballow, et al.
The Journal of Allergy and Clinical Immunology|February 17, 2022
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response CommitteesIris M Otani, Heather K Lehman, Artemio M Jongco, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2017
Update on the use of immunoglobulin in human disease: A review of evidenceElena E Perez, Jordan S Orange, Francisco Bonilla, et al.
Journal of Clinical Immunology|March 1, 2014
Newborn screening for SCID in New York State: experience from the first two yearsBeth H Vogel, Vincent Bonagura, Geoffrey A Weinberg, et al.
The Journal of Allergy and Clinical Immunology|April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJordan S Orange, Elham M Hossny, Catherine R Weiler, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & ImmunologyJordan S Orange, Mark Ballow, E Richard Stiehm, et al.
Pageof 10